Stryker Corporation (SYK) Return on Equity (ROE): 14.52%
Is Stryker Corporation’s return on equity (ROE) high or low?
Stryker Corporation's return on equity (ROE) of 14.52% is in line with its 5-year average of 14.30%, around the middle of its 5-year range (12.22%–17.02%).
As of Wednesday, June 17, 2026. 0.17% above its 12-month average of 14.50%.
SYK Return on Equity (ROE) Chart
SYK Average Return on Equity (ROE) Chart
SYK Current vs Average Return on Equity (ROE) Chart
SYK Return on Equity (ROE) Metrics
RETURN ON EQUITY (ROE)
14.52%
RETURN ON EQUITY (ROE) AVG TTM
14.50%
RETURN ON EQUITY (ROE) AVG 3Y
15.05%
RETURN ON EQUITY (ROE) AVG 5Y
14.30%
RETURN ON EQUITY (ROE) AVG 10Y
16.07%
RETURN ON EQUITY (ROE) AVG 15Y
14.85%
RETURN ON EQUITY (ROE) AVG 20Y
16.00%
CURRENT VS TTM AVG
+0.17%
CURRENT VS 3Y AVG
-3.52%
CURRENT VS 5Y AVG
+1.51%
CURRENT VS 10Y AVG
-9.64%
CURRENT VS 15Y AVG
-2.25%
CURRENT VS 20Y AVG
-9.22%
SYK Competitors' Return on Equity (ROE)
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Stryker Corporation (SYK) | $119.06B | 14.52% | 14.50% | 15.05% | 14.30% |
| Bristol-Myers Squibb Company (BMY)vs › | $114.38B | 36.25% | -8.30% | 7.76% | 4.45% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $113.82B | 22.41% | 8.96% | 15.60% | 19.47% |
| CVS Health Corporation (CVS)vs › | $127.54B | 3.79% | 4.23% | 6.35% | 7.74% |
| Danaher Corporation (DHR)vs › | $128.72B | 6.97% | 7.38% | 9.51% | 10.24% |
| Medtronic plc (MDT)vs › | $104.05B | 9.80% | 4.86% | 6.08% | 6.82% |
| Intuitive Surgical, Inc. (ISRG)vs › | $148.26B | 17.05% | 15.07% | 13.91% | 13.46% |
| Pfizer Inc. (PFE)vs › | $148.76B | 8.31% | 9.04% | 13.32% | 16.07% |
| HCA Healthcare, Inc. (HCA)vs › | $88.05B | -112.56% | -171.53% | -210.62% | -155.29% |
| Elevance Health Inc. (ELV)vs › | $86.74B | 11.94% | 13.69% | 14.71% | 14.93% |
Return Analysis
ROE
14.5%
ROA
7.2%
Stryker Corporation Return on Equity (ROE) Formula & Definition
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Stryker Corporation Return on Equity (ROE) FAQ
- What is the return on equity (ROE) for Stryker Corporation (SYK)?
- The return on equity (ROE) for SYK stock is 14.52%.
- Is Stryker Corporation's return on equity (ROE) high or low?
- Stryker Corporation's return on equity (ROE) of 14.52% is in line with its 5-year average of 14.30%, around the middle of its 5-year range (12.22%–17.02%).
- What is the TTM average return on equity (ROE) for Stryker Corporation (SYK)?
- The TTM average return on equity (ROE) for SYK stock is 14.50%.
- What is the 3Y average return on equity (ROE) for Stryker Corporation (SYK)?
- The 3Y average return on equity (ROE) for SYK stock is 15.05%.
- What is the 5Y average return on equity (ROE) for Stryker Corporation (SYK)?
- The 5Y average return on equity (ROE) for SYK stock is 14.30%.
- What is the 10Y average return on equity (ROE) for Stryker Corporation (SYK)?
- The 10Y average return on equity (ROE) for SYK stock is 16.07%.
- What is the 15Y average return on equity (ROE) for Stryker Corporation (SYK)?
- The 15Y average return on equity (ROE) for SYK stock is 14.85%.
- What is the 20Y average return on equity (ROE) for Stryker Corporation (SYK)?
- The 20Y average return on equity (ROE) for SYK stock is 16.00%.
Stryker Corporation Return on Equity (ROE) History
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | 14.48% |
| 2024-12-31 | 14.51% |
| 2023-12-31 | 17.02% |
| 2022-12-31 | 14.19% |
| 2021-12-31 | 13.40% |
| 2020-12-31 | 12.22% |
| 2019-12-31 | 16.26% |
| 2018-12-31 | 30.29% |
| 2017-12-31 | 10.23% |
| 2016-12-31 | 17.25% |
| 2015-12-31 | 16.91% |
| 2014-12-31 | 5.99% |
| 2013-12-31 | 11.12% |
| 2012-12-31 | 15.10% |
| 2011-12-31 | 17.51% |
| 2010-12-31 | 17.75% |
| 2009-12-31 | 16.79% |
| 2008-12-31 | 21.23% |
| 2007-12-31 | 18.92% |
| 2006-12-31 | 18.56% |
| 2005-12-31 | 20.46% |
| 2004-12-31 | 16.92% |
| 2003-12-31 | 21.05% |
| 2002-12-31 | 23.07% |
| 2001-12-31 | 25.28% |
| 2000-12-31 | 25.85% |
| 1999-12-31 | 2.89% |
| 1998-12-31 | 6.07% |
| 1997-12-31 | 20.45% |
| 1996-12-31 | 19.70% |
Related Metrics
About Stryker Corporation
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Kevin A. Lobo